FDA.reportPublic FDA data

Pharbetol

Manufacturer
A-S Medication Solutions
Effective date
2023-02-04
Label type
HUMAN OTC DRUG LABEL
Version
20
Source
legacy-cache
Hydrated at
2026-08-01 21:37:32

Label at a glance#

ProductPharbetol
Active ingredientACETAMINOPHEN
Label structure10 sections

Indications and uses

temporarily relieves minor aches and pains due to: the common cold headache backache minor pain of arthritis toothache muscular aches premenstrual and menstrual cramps temporarily reduces fever

Dosage and administration

do not take more than directed (see overdose warning). adult and children 12 years and over take 2 tablets, every 4 to 6 hours while symptoms last do not take more than 6 tablets in 24 hours, unless directed by a doctor do not use for more than 10 days unless directed by a doctor children under 12 years Ask a doctor

Label contents#

Full prescribing information#

Active ingredient (in each tablet)

OTC - ACTIVE INGREDIENT SECTION

Acetaminophen 500 mg

Purpose

OTC - PURPOSE SECTION

Pain reliever/fever reducer

Uses

INDICATIONS & USAGE SECTION

  • temporarily relieves minor aches and pains due to:
  • the common cold
  • headache
  • backache
  • minor pain of arthritis
  • toothache
  • muscular aches
  • premenstrual and menstrual cramps
  • temporarily reduces fever

Warnings

WARNINGS SECTION

Liver warning: This product contains acetaminophen. Severe liver damage may occur if you take

  • more than 8 tablets in 24 hours, which is the maximum daily amount
  • with other drugs containing acetaminophen
  • 3 or more alcoholic drinks every day while using this product

Allergy alert: acetaminophen may cause severe skin reactions. Symptoms may include:

  • skin reddening
  • blisters
  • rash

If a skin reaction occurs, stop use and seek medical help right away.

Do not use

OTC - DO NOT USE SECTION

  • with any other drug containing acetaminophen (prescription or nonprescription). If you are not sure whether a drug contains acetaminophen, ask a doctor or pharmacist
  • if you are allergic to acetaminophen or any of the inactive ingredients in this product

Ask a doctor before use if you have

OTC - ASK DOCTOR SECTION

liver disease.

Ask a doctor or pharmacist before use if you are

OTC - ASK DOCTOR/PHARMACIST SECTION

taking the blood thinning drug warfarin.

Stop use and ask a doctor if

OTC - STOP USE SECTION

  • pain gets worse or lasts more than 10 days
  • fever gets worse or lasts more than 3 days
  • new symptoms occur
  • redness or swelling is present

These could be signs of a serious condition.

If pregnant or breast-feeding,

OTC - PREGNANCY OR BREAST FEEDING SECTION

ask a health professional before use.

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Overdose warning: In case of overdose, get medical help or contact a Poison Control Center right away. (1-800-222-1222)

Directions

DOSAGE & ADMINISTRATION SECTION

  • do not take more than directed (see overdose warning).

adult and children 12 years and over

  • take 2 tablets, every 4 to 6 hours while symptoms last
  • do not take more than 6 tablets in 24 hours, unless directed by a doctor
  • do not use for more than 10 days unless directed by a doctor

children under 12 years

Ask a doctor

Other information

OTHER SAFETY INFORMATION

  • Tamper Evident: do not use if imprinted safety seal under cap is broken or missing
  • store between 20-250 C (68-77 0 F)

Inactive ingredients

INACTIVE INGREDIENT SECTION

povidone, pregelatinized corn starch, sodium starch glycolate, stearic acid

Questions?

OTC - QUESTIONS SECTION

Adverse drug event call: 1-866-562-2756 Mon - Fri: 8 AM to 4 PM

HOW SUPPLIED

HOW SUPPLIED SECTION

Product: 50090-0395

NDC: 50090-0395-0 15 TABLET in a BOTTLE

NDC: 50090-0395-1 30 TABLET in a BOTTLE

NDC: 50090-0395-2 100 TABLET in a BOTTLE

NDC: 50090-0395-3 50 TABLET in a BOTTLE

NDC: 50090-0395-4 24 TABLET in a BOTTLE

NDC: 50090-0395-5 20 TABLET in a BOTTLE

NDC: 50090-0395-8 2 TABLET in a BOTTLE

Acetaminophen

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Label Image
Label Image

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
50090-0395-02023-02-07C16284748780-1f386c649-9d3a-0266-e053-dadaa90a7c1aDrug Facts
50090-0395-12023-02-07C16284748780-1f386c649-9d3a-0266-e053-dadaa90a7c1aDrug Facts
50090-0395-22023-02-07C16284748780-1f386c649-9d3a-0266-e053-dadaa90a7c1aDrug Facts
50090-0395-32023-02-07C16284748780-1f386c649-9d3a-0266-e053-dadaa90a7c1aDrug Facts
50090-0395-42023-02-07C16284748780-1f386c649-9d3a-0266-e053-dadaa90a7c1aDrug Facts
50090-0395-52023-02-07C16284748780-1f386c649-9d3a-0266-e053-dadaa90a7c1aDrug Facts
50090-0395-82023-02-07C16284748780-1f386c649-9d3a-0266-e053-dadaa90a7c1aDrug Facts
50090-0395-02023-01-30C16284748780-1f386c649-9d3a-0266-e053-dadaa90a7c1aDrug Facts
50090-0395-12023-01-30C16284748780-1f386c649-9d3a-0266-e053-dadaa90a7c1aDrug Facts
50090-0395-22023-01-30C16284748780-1f386c649-9d3a-0266-e053-dadaa90a7c1aDrug Facts
50090-0395-32023-01-30C16284748780-1f386c649-9d3a-0266-e053-dadaa90a7c1aDrug Facts
50090-0395-42023-01-30C16284748780-1f386c649-9d3a-0266-e053-dadaa90a7c1aDrug Facts
50090-0395-52023-01-30C16284748780-1f386c649-9d3a-0266-e053-dadaa90a7c1aDrug Facts
50090-0395-82023-01-30C16284748780-1f386c649-9d3a-0266-e053-dadaa90a7c1aDrug Facts

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
50090-0395-0EA - Each50090-0395e50bb63c-9567-4d2a-9bc1-9dabb9c40a7412018-09-05
50090-0395-1EA - Each50090-0395a7318c53-2a00-4583-86f3-1a1ed057253812018-09-05
50090-0395-2EA - Each50090-039541d46d62-cd1c-409d-80f1-d8b34232066c12018-09-05
50090-0395-3EA - Each50090-03958efc4c61-188a-4ef3-8970-427d42ae58b812018-09-05
50090-0395-4EA - Each50090-03951918e45a-fbba-461e-b03c-f924436dea4312018-09-05
50090-0395-5EA - Each50090-0395184b46d2-004d-49c8-acd6-1e72725cd87a12018-09-05
50090-0395-8EA - Each50090-0395af310dac-226d-4b35-a2c4-6a3e990d497f12018-09-05
16103-376-06EA - Each16103-376b0ec28db-7535-413e-805f-e1416eeca91812012-07-24
16103-376-08EA - Each16103-376b9284189-e1cd-4f69-88be-fb02466b57ca12012-07-24
16103-376-11EA - Each16103-3767d6a6a6a-b98e-44d2-8664-e2351539d62b12012-07-24

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 6 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
50090-039550090-0395-8, 50090-0395-2, 50090-0395-5, 50090-0395-0, 50090-0395-3, 50090-0395-4, 50090-0395-1
16103-376

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 5 matching rows.

Name, UNII, Kind table
NameUNIIKind
ACETAMINOPHEN362O9ITL9DACTIB
POVIDONE, UNSPECIFIEDFZ989GH94EIACT
STARCH, CORNO8232NY3SJIACT
SODIUM STARCH GLYCOLATE TYPE A POTATO5856J3G2A2IACT
STEARIC ACID4ELV7Z65APIACT

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
PharbetolACETAMINOPHENPharbest Pharmaceuticals, Inc.04dbd98f-c74d-43b2-8bda-74f18be7cf6c2025-12-24WarningsExact identifier
ndc (product): 16103-376
3e346053-953d-4f11-9a77-5cc80de40bf8722ea0b1-1455-443f-bed1-12daa43b71b42024-09-05WarningsExact identifier
spl set id: 722ea0b1-1455-443f-bed1-12daa43b71b4

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.